Quels risques sont associés à une grossesse multiple ?
Les grossesses multiples augmentent le risque de complications pour la mère et les bébés.
Grossesse multipleGonadotrophine chorionique
#4
La gonadotrophine chorionique peut-elle causer des problèmes de santé mentale ?
Des fluctuations hormonales peuvent affecter l'humeur et provoquer de l'anxiété.
Santé mentaleGonadotrophine chorionique
#5
Quels sont les effets à long terme de la gonadotrophine chorionique ?
Les effets à long terme sont généralement rares, mais un suivi est recommandé.
Effets à long termeGonadotrophine chorionique
Facteurs de risque
5
#1
Quels facteurs augmentent le risque d'hyperstimulation ovarienne ?
L'âge, le poids et des antécédents d'hyperstimulation augmentent ce risque.
Hyperstimulation ovarienneFacteurs de risque
#2
Comment l'âge influence-t-il la fertilité ?
L'âge avancé peut réduire la qualité des ovules et augmenter les risques de complications.
ÂgeFertilité
#3
Les antécédents médicaux influencent-ils la réponse à la gonadotrophine chorionique ?
Oui, des antécédents de troubles hormonaux peuvent affecter la réponse au traitement.
Antécédents médicauxGonadotrophine chorionique
#4
Quels comportements de santé peuvent affecter la fertilité ?
Le tabagisme, l'alcool et le stress peuvent nuire à la fertilité et à la réponse hormonale.
Comportements de santéFertilité
#5
Y a-t-il des facteurs environnementaux qui influencent la fertilité ?
Oui, l'exposition à des toxines environnementales peut affecter la fertilité.
Facteurs environnementauxFertilité
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Gonadotrophine chorionique : Questions médicales les plus fréquentes",
"headline": "Gonadotrophine chorionique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Gonadotrophine chorionique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-18",
"dateModified": "2025-03-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Gonadotrophine chorionique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines de la grossesse",
"url": "https://questionsmedicales.fr/mesh/D011257",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de la grossesse",
"code": {
"@type": "MedicalCode",
"code": "D011257",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.780"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Gonadotrophine chorionique",
"alternateName": "Chorionic Gonadotropin",
"code": {
"@type": "MedicalCode",
"code": "D006063",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Hirokazu Usui",
"url": "https://questionsmedicales.fr/author/Hirokazu%20Usui",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, Reproductive Medicine, Chiba University Graduate School of Medicine, Chiba, Japan."
}
},
{
"@type": "Person",
"name": "Asuka Sato",
"url": "https://questionsmedicales.fr/author/Asuka%20Sato",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, Chiba University Hospital, Chiba University, Chiba, Japan."
}
},
{
"@type": "Person",
"name": "Eri Katayama",
"url": "https://questionsmedicales.fr/author/Eri%20Katayama",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, Chiba University Hospital, Chiba University, Chiba, Japan."
}
},
{
"@type": "Person",
"name": "Natsuko Nakamura",
"url": "https://questionsmedicales.fr/author/Natsuko%20Nakamura",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, Chiba University Hospital, Chiba University, Chiba, Japan."
}
},
{
"@type": "Person",
"name": "Kaori Koga",
"url": "https://questionsmedicales.fr/author/Kaori%20Koga",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, Reproductive Medicine, Chiba University Graduate School of Medicine, Chiba, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A novel MAMLD1 variant in a newborn with hypospadias and elevated 17-hydroxyprogesterone.",
"datePublished": "2023-11-24",
"url": "https://questionsmedicales.fr/article/37996649",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s42000-023-00513-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Regional differences in utilization of 17α-hydroxyprogesterone caproate (17-OHP).",
"datePublished": "2022-06-03",
"url": "https://questionsmedicales.fr/article/35654442",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1515/jpm-2021-0586"
}
},
{
"@type": "ScholarlyArticle",
"name": "An unusual cause of adrenal insufficiency with elevation of 17-hydroxyprogesterone: case report.",
"datePublished": "2023-05-29",
"url": "https://questionsmedicales.fr/article/37246209",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12902-023-01374-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Relationship between plasma concentration of 17-hydroxyprogesterone caproate and gestational age at preterm delivery.",
"datePublished": "2023-04-24",
"url": "https://questionsmedicales.fr/article/37100349",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ajogmf.2023.100980"
}
},
{
"@type": "ScholarlyArticle",
"name": "Racial and ethnic representation in 17-hydroxyprogesterone caproate preterm birth prevention studies: a systematic review.",
"datePublished": "2022-08-29",
"url": "https://questionsmedicales.fr/article/36027908",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1515/jpm-2021-0425"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines de la grossesse",
"item": "https://questionsmedicales.fr/mesh/D011257"
},
{
"@type": "ListItem",
"position": 5,
"name": "Gonadotrophine chorionique",
"item": "https://questionsmedicales.fr/mesh/D006063"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Gonadotrophine chorionique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Gonadotrophine chorionique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Gonadotrophine chorionique",
"description": "Comment se diagnostique une grossesse avec la gonadotrophine chorionique ?\nQuels niveaux de gonadotrophine indiquent une grossesse normale ?\nPeut-on utiliser la gonadotrophine chorionique pour diagnostiquer des tumeurs ?\nQuels tests sont utilisés pour mesurer la gonadotrophine chorionique ?\nQuand doit-on mesurer la gonadotrophine chorionique après la conception ?",
"url": "https://questionsmedicales.fr/mesh/D006063?mesh_terms=17-alpha-Hydroxyprogesterone#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Gonadotrophine chorionique",
"description": "Quels symptômes indiquent une grossesse précoce ?\nLa gonadotrophine chorionique cause-t-elle des effets secondaires ?\nQuels signes peuvent indiquer une grossesse extra-utérine ?\nComment la gonadotrophine chorionique affecte-t-elle l'humeur ?\nQuels symptômes peuvent indiquer une hyperstimulation ovarienne ?",
"url": "https://questionsmedicales.fr/mesh/D006063?mesh_terms=17-alpha-Hydroxyprogesterone#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Gonadotrophine chorionique",
"description": "Peut-on prévenir les complications liées à la gonadotrophine chorionique ?\nComment réduire le risque de grossesse extra-utérine ?\nY a-t-il des mesures préventives pour l'hyperstimulation ovarienne ?\nComment le mode de vie influence-t-il la fertilité ?\nLes femmes doivent-elles se faire dépister avant un traitement de fertilité ?",
"url": "https://questionsmedicales.fr/mesh/D006063?mesh_terms=17-alpha-Hydroxyprogesterone#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Gonadotrophine chorionique",
"description": "Comment la gonadotrophine chorionique est-elle utilisée en fertilité ?\nQuels sont les traitements pour les niveaux anormaux de gonadotrophine ?\nLa gonadotrophine chorionique est-elle utilisée pour traiter des tumeurs ?\nQuels médicaments contiennent de la gonadotrophine chorionique ?\nComment la gonadotrophine chorionique est-elle administrée ?",
"url": "https://questionsmedicales.fr/mesh/D006063?mesh_terms=17-alpha-Hydroxyprogesterone#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Gonadotrophine chorionique",
"description": "Quelles sont les complications possibles de la gonadotrophine chorionique ?\nComment l'hyperstimulation ovarienne se manifeste-t-elle ?\nQuels risques sont associés à une grossesse multiple ?\nLa gonadotrophine chorionique peut-elle causer des problèmes de santé mentale ?\nQuels sont les effets à long terme de la gonadotrophine chorionique ?",
"url": "https://questionsmedicales.fr/mesh/D006063?mesh_terms=17-alpha-Hydroxyprogesterone#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Gonadotrophine chorionique",
"description": "Quels facteurs augmentent le risque d'hyperstimulation ovarienne ?\nComment l'âge influence-t-il la fertilité ?\nLes antécédents médicaux influencent-ils la réponse à la gonadotrophine chorionique ?\nQuels comportements de santé peuvent affecter la fertilité ?\nY a-t-il des facteurs environnementaux qui influencent la fertilité ?",
"url": "https://questionsmedicales.fr/mesh/D006063?mesh_terms=17-alpha-Hydroxyprogesterone#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment se diagnostique une grossesse avec la gonadotrophine chorionique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un test sanguin ou urinaire détecte la présence de la gonadotrophine chorionique."
}
},
{
"@type": "Question",
"name": "Quels niveaux de gonadotrophine indiquent une grossesse normale ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux de 5 à 426 mUI/ml sont typiques au début de la grossesse."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser la gonadotrophine chorionique pour diagnostiquer des tumeurs ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés peuvent indiquer des tumeurs germinales ou trophoblastiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour mesurer la gonadotrophine chorionique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests immunologiques, comme les tests ELISA, sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quand doit-on mesurer la gonadotrophine chorionique après la conception ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle doit être mesurée environ 1 à 2 semaines après la conception."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une grossesse précoce ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des seins sensibles et des retards de règles."
}
},
{
"@type": "Question",
"name": "La gonadotrophine chorionique cause-t-elle des effets secondaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut provoquer des nausées et des vomissements chez certaines femmes."
}
},
{
"@type": "Question",
"name": "Quels signes peuvent indiquer une grossesse extra-utérine ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Douleurs abdominales sévères et saignements peuvent signaler une grossesse extra-utérine."
}
},
{
"@type": "Question",
"name": "Comment la gonadotrophine chorionique affecte-t-elle l'humeur ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des fluctuations hormonales peuvent entraîner des changements d'humeur chez certaines femmes."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une hyperstimulation ovarienne ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ballonnements, douleurs abdominales et prise de poids rapide peuvent survenir."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les complications liées à la gonadotrophine chorionique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et des tests précoces peuvent aider à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque de grossesse extra-utérine ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical et une gestion des facteurs de risque peuvent réduire ce risque."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures préventives pour l'hyperstimulation ovarienne ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surveillance attentive lors des traitements de fertilité peut prévenir l'hyperstimulation."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie influence-t-il la fertilité ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, y compris une alimentation équilibrée, peut améliorer la fertilité."
}
},
{
"@type": "Question",
"name": "Les femmes doivent-elles se faire dépister avant un traitement de fertilité ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un dépistage complet est recommandé pour identifier les problèmes de fertilité."
}
},
{
"@type": "Question",
"name": "Comment la gonadotrophine chorionique est-elle utilisée en fertilité ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est administrée pour induire l'ovulation et soutenir la grossesse."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements pour les niveaux anormaux de gonadotrophine ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend de la cause sous-jacente, comme des médicaments ou une chirurgie."
}
},
{
"@type": "Question",
"name": "La gonadotrophine chorionique est-elle utilisée pour traiter des tumeurs ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être utilisée dans le traitement de certains types de tumeurs germinales."
}
},
{
"@type": "Question",
"name": "Quels médicaments contiennent de la gonadotrophine chorionique ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme l'HCG sont utilisés pour la fertilité et le traitement hormonal."
}
},
{
"@type": "Question",
"name": "Comment la gonadotrophine chorionique est-elle administrée ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est généralement administrée par injection intramusculaire ou sous-cutanée."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la gonadotrophine chorionique ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'hyperstimulation ovarienne et les grossesses multiples."
}
},
{
"@type": "Question",
"name": "Comment l'hyperstimulation ovarienne se manifeste-t-elle ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par des douleurs abdominales, des nausées et un gonflement abdominal."
}
},
{
"@type": "Question",
"name": "Quels risques sont associés à une grossesse multiple ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les grossesses multiples augmentent le risque de complications pour la mère et les bébés."
}
},
{
"@type": "Question",
"name": "La gonadotrophine chorionique peut-elle causer des problèmes de santé mentale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des fluctuations hormonales peuvent affecter l'humeur et provoquer de l'anxiété."
}
},
{
"@type": "Question",
"name": "Quels sont les effets à long terme de la gonadotrophine chorionique ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets à long terme sont généralement rares, mais un suivi est recommandé."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'hyperstimulation ovarienne ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge, le poids et des antécédents d'hyperstimulation augmentent ce risque."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il la fertilité ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé peut réduire la qualité des ovules et augmenter les risques de complications."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils la réponse à la gonadotrophine chorionique ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de troubles hormonaux peuvent affecter la réponse au traitement."
}
},
{
"@type": "Question",
"name": "Quels comportements de santé peuvent affecter la fertilité ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme, l'alcool et le stress peuvent nuire à la fertilité et à la réponse hormonale."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux qui influencent la fertilité ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines environnementales peut affecter la fertilité."
}
}
]
}
]
}
Laboratory of Physiopathology and PharmacoToxicology of the Human Placenta, UMR-S 1139 Inserm - University Paris Descartes, Sorbonne Paris Cité, Paris, France.
Animal Biotechnology, Graduate School of Future Convergence Technology, Institute of Genetic Engineering, Hankyong National University, Ansung, 17579, Korea.
Animal Biotechnology, Graduate School of Future Convergence Technology, Institute of Genetic Engineering, Hankyong National University, Ansung, 17579, Korea. ksmin@hknu.ac.kr.
School of Animal Life Biotechnology, Institute of Genetic Engineering, Hankyong National University, Ansung, 17579, Korea. ksmin@hknu.ac.kr.
Department of Surgery, Dentistry, Paediatrics and Gynaecology, Paediatric Fertility Lab, Woman and Child Hospital, Division of Pediatric Surgery, University of Verona, 37134 Verona, Italy.
Department of Obstetrics and Gynaecology, Reproductive Endocrinology and Infertility Unit, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Department of Obstetrics and Gynaecology, Reproductive Endocrinology and Infertility Unit, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Department of Obstetrics and Gynaecology, Reproductive Endocrinology and Infertility Unit, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Disorders of sex development (DSD) have complex pathogenesis, and evidence suggests an association between MAMLD1 defects and DSD. MAMLD1 is expressed in gonadal tissues and affected males exhibit hyp...
Genetic testing of the proband and parents was conducted using whole-exome and Sanger sequencing. The identified variant was transfected into HEK293T cells to assess mutant protein expression using we...
A novel heterozygous variant was identified in the proband's MAMLD1, NM_005491.5: c.1619_1637del (p.Gln540Alafs*72), inherited from the mother. In transfected cells, the wild-type and mutant proteins ...
Severe hypospadias in the proband may be attributed to a novel MAMLD1 variant, whereas the 17α-OH elevation might be related to interference with CYP17A1 transcriptional activation. This study expands...
To describe regional differences in utilization of 17α-hydroxyprogesterone caproate (17-OHP)....
Retrospective cohort study of a large, US commercial managed care plan claims database with pharmacy coverage from 2008 to 2018. Singleton pregnancies with at least one prior spontaneous preterm birth...
Of the 4,514 individuals with an indication for 17-OHP, 580 (12.8%) were prescribed 17-OHP. Regional and state-based differences in 17-OHP utilization were identified; Northeast 15.7%, Midwest 13.7%, ...
While significant regional differences in 17-OHP utilization were demonstrated, 17-OHP utilization remained low despite this cohort having insurance through a US commercial managed care plan. Suboptim...
We present an intriguing case of primary adrenal lymphoma, with associated primary adrenal insufficiency (PAI), in a patient presenting a transitory partial 21-hydroxylase deficiency during the active...
An 85-years old woman was referred because of worsening asthenia, lumbar pain, generalized myalgia and arthralgia. During investigations a computed tomography (CT) scan evidenced two large bilateral a...
In the presence of bilateral adrenal disease and/or in the presence of signs and symptoms of PAI clinicians must exclude the presence of PAL. The evidence of elevated ACTH-stimulated 17-OHP levels als...
The effectiveness of 17-hydroxyprogesterone caproate is unclear as trials have provided conflicting results. With the absence of fundamental pharmacologic studies addressing dosing or the relationship...
This study aimed to evaluate the relationship between plasma concentrations of 17-hydroxyprogesterone caproate and preterm birth rates and gestational age at preterm delivery and to assess the safety ...
This study recruited 2 cohorts with previous spontaneous preterm birth; 1 cohort (n=143) was randomly assigned to either 250-mg or 500-mg 17-hydroxyprogesterone caproate, and the other cohort (n=16) w...
There was a dose proportional increase in trough plasma concentrations with the 250-mg (median, 8.6 ng/m; n=66) and 500-mg (median, 16.2 ng/mL; n=55) doses. In 116 compliant participants with blood sa...
In this pharmacodynamic study, trough plasma 17-hydroxyprogesterone caproate concentrations were significantly associated with gestational age at preterm birth but not with the preterm birth rate. Pos...
The US preterm birth rate varies dramatically by race and ethnicity yet the racial and ethnic representation within studies evaluating 17-hydroxprogesterone caproate (17-P) for preterm birth preventio...
We systematically reviewed US studies published between January 2000 and December 2019. Study participant's race and ethnicity were reported using descriptive statistics then compared to US 2017//2018...
Eighteen studies met the inclusion criteria, 17 studies reported race, 11 studies reported ethnicity, and yet none of the studies followed the NIH criteria. Compared to 2017/2018 US preterm births, th...
More detailed reporting of race and ethnicity is needed in 17-P literature. Black women appear to be well represented while other racial and ethnic groups may be understudied....
The IPOP trial demonstrated a reduced risk of severe small for gestational age among infants born to women with HIV who received weekly intramuscular 17 alpha-hydroxyprogesterone caproate. This second...
Children with classical congenital adrenal hyperplasia (CAH) have an impaired steroid synthesis due to 21-hydroxylase dysfunction and require glucocorticoid replacement. Therapy management in children...
In this retrospective and longitudinal study of 22 patients with CAH, we analyzed 546 saliva samples for 17-hydroxyprogesterone (s17-OHP) in prepubertal/pubertal patients. Additionally, we correlated ...
We analyzed a median observation period of 5.5 years per patient. No precocious pubertal development, abnormal vital signs, or Addison crises occurred. 57.1% of the samples were collected in prepubert...
The measurement of s17-OHP is an important sub-aspect in the overall assessment of treatment response in CAH. It can provide an indication of over-/undertreatment and allows the assessment of day prof...
Newborn screening for congenital adrenal hyperplasia (CAH) has benefits with a high adoption rate worldwide. It also has problems of high false positives, which can cause stress to the patient's famil...
Newborns (n=1,071) born between October 2020 and January 2022 were screened for CAH. Samples from neonates were collected on filter paper with the heel prick method. 17-OHP concentration was measured ...
The median age of newborns at neonatal sample collection was 6 days. 17-OHP concentration showed a statistically significant negative correlation with BW (...
This study presents new 17-OHP cutoff values for preterm, LBW, and sick newborns. These data in our laboratory can be used as a reference by other laboratories for establishing new cutoff criteria to ...
Quantifying small amounts of the 17-hydroxyprogesterone in various matrix is crucial for different purposes. In this study, a commercial polydimethylsiloxane stir bar was used to extract hormone from ...
Androgens play important roles in polycystic ovarian syndrome (PCOS). However, measures of androgens based on mass spectrometry (MS) remain complex due to endogenous inferences of isomers or compounds...
We developed a fast and sensitive high-performance liquid chromatography-differential mobility spectrometry tandem mass spectrometry (HPLC-DMS/MS/MS) method for the simultaneous determination of seven...
Linear ranges of the eight analytes were set in terms of clinical use. Intra- and inter-run precisions were < 16.7 % and 12.9 % for all the analytes and relative error was - 14.7-13.3 % and - 9.3-11.0...
The developed method is green, fast, sensitive and accurate for the determination of endogenous androgens. It can be readily implemented in medical laboratories to provide superior analytical performa...